• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Chemother . Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19

tetano

Editor, Senior Moderator
Infect Chemother


. 2021 Jun;53(2):308-318.
doi: 10.3947/ic.2021.0024.
Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19


Somayeh Hajiahmadi[SUP] 1 [/SUP], Azin Shayganfar[SUP] 1 [/SUP], Mohsen Janghorbani[SUP] 2 [/SUP], Mahsa Masjedi Esfahani[SUP] 3 [/SUP], Mehdi Mahnam[SUP] 4 5 [/SUP], Nagar Bakhtiarvand[SUP] 4 [/SUP], Ramin Sami[SUP] 6 [/SUP], Nilufar Khademi[SUP] 1 [/SUP], Mehrnegar Dehghani[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The novel coronavirus disease 2019 (COVID-19) continues to wreak havoc worldwide. This study assessed the ability of chest computed tomography (CT) severity score (CSS) to predict intensive care unit (ICU) admission and mortality in patients with COVID-19 pneumonia.
Materials and methods: A total of 192 consecutive patients with COVID-19 pneumonia aged more than 20 years and typical CT findings and reverse-transcription polymerase chain reaction positive admitted in a tertiary hospital were included. Clinical symptoms at admission and short-term outcome were obtained. A semi-quantitative scoring system was used to evaluate the parenchymal involvement. The association between CSS, disease severity, and outcomes were evaluated. Prediction of CSS was assessed with the area under the receiver-operating characteristic (ROC) curves.
Results: The incidence of admission to ICU was 22.8% in men and 14.1% in women. CSS was related to ICU admission and mortality. Areas under the ROC curves were 0.764 for total CSS. Using a stepwise binary logistic regression model, gender, age, oxygen saturation, and CSS had a significant independent relationship with ICU admission and death. Patients with CSS ≥12.5 had about four-time risk of ICU admission and death (odds ratio 1.66, 95% confidence interval 1.66 - 9.25). The multivariate regression analysis showed the superiority of CSS over other clinical information and co-morbidities.
Conclusion: CSS was a strong predictor of progression to ICU admission and death and there was a substantial role of non-contrast chest CT imaging in the presence of typical features for COVID-19 pneumonia as a reliable predictor of clinical severity and patient's outcome.

Keywords: COVID-19; CT severity score; Chest CT; Prognosis; SARS-CoV-2.
 
Back
Top Bottom